Ledger.Open graph →
SEC Form D · Amendment · filed October 4, 2018

Receptor Life Sciences, Inc

Offering
$7.6M
Sold
$7.6M
Exemption
Rule 506(b)
Industry
Other
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Arthur Rubinfeld · Seattle, WADirectorGregory Wesner · Seattle, WADirectorMichael H. Christopher · Wayne, PADirectorDavid M. Diehl · OAKBROOK TERRACE, ILDirectorDavid Thomson · San Francisco, CADirectorTraci Carman · Seattle, WAExec · DirectorRishi Bajaj · Newport Beach, CADirectorVy H. Le · Grand Cayman, Cayman IslandsDirectorDavid Thomson · Seattle, WADirectorTraci Carman · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗